文献速递牙周病

抑制Ctsk通过下调TLR9信号通路缓解牙周炎与类风湿关节炎共病

Inhibition of Ctsk alleviates periodontitis and comorbid rheumatoid arthritis via downregulation of the TLR9 signalling pathway.
PubMed 文献 · J Clin Periodontol · 2019-03-10

该研究在DBA/1小鼠中建立牙周炎合并关节炎模型,评估Ctsk特异性抑制剂BML-244对TLR9信号通路及炎症的影响。结果显示共病导致更严重的牙周骨与关节软骨破坏,抑制Ctsk可减少免疫细胞浸润和炎症因子产生,并减轻硬组织侵蚀,且Ctsk特异性参与TLR9介导的细胞因子产生。

要点

  • 牙周炎与类风湿关节炎共病可加重牙周骨和关节软骨破坏。
  • 抑制Ctsk可减轻共病模型中的免疫浸润与硬组织侵蚀。
  • Ctsk通过TLR9通路参与牙周炎和类风湿关节炎的病理过程。

核心结论

  • 牙周炎与类风湿关节炎可能通过TLR9通路失调产生叠加病理效应。
  • Ctsk是该通路的关键介质,参与两种疾病的发病过程。

研究设计与样本

  • 在DBA/1小鼠中建立牙周炎合并关节炎的实验模型。
  • 体内和体外实验检测Ctsk特异性抑制剂BML-244对TLR9信号通路炎症标志物的影响。

主要发现

  • 牙周炎-类风湿关节炎共病导致比单一疾病更严重的牙周骨和关节软骨破坏。
  • 抑制Ctsk减少树突状细胞和T细胞浸润及炎症因子产生。
  • 抑制Ctsk减轻牙周病变骨侵蚀和膝关节软骨破坏。
  • 抑制Ctsk在体内降低TLR4和TLR9表达。
  • 体外实验表明Ctsk特异性参与TLR9 engagement后的细胞因子产生。

临床怎么用

  • Ctsk可能作为治疗牙周炎与类风湿关节炎共病的新靶点。
  • TLR9信号通路失调可能是共病加重的机制之一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: In this study, we investigate the mechanistic link between rheumatoid arthritis (RA) and periodontitis to identify a novel target (cathepsin K; Ctsk) for the treatment of comorbid periodontitis and RA. METHODS: An experimental model of periodontitis with arthritis was established in DBA/1 mice. We then tested the effect of BML-244, a specific inhibitor of Ctsk, by quantifying several inflammatory markers of TLR9 signalling both in vivo and in vitro. RESULTS: Our results showed that periodontitis-rheumatoid arthritis comorbidity causes severer periodontal bone and joint cartilage destruction than either disease alone. Inhibition of Ctsk reduced infiltration by dendritic cells and T cells and inflammatory cytokine production; these improvements alleviated the hard-tissue erosion in periodontitis and RA as measured by bone erosion in periodontal lesions and cartilage destruction in knee joints. Inhibition of Ctsk also decreased the expression of TLR4 and TLR9 in vivo, whereas in vitro experiments indicated that Ctsk is involved specifically in the production of cytokines in response to TLR9 engagement. CONCLUSION: Our data reveal that periodontitis and RA may have additive pathological effects through dysregulation of the TLR9 pathway and that Ctsk is a critical mediator of this pathway and contributes to the pathogenesis of RA and periodontitis.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Pan W, Yin W, Yang L, et al. Inhibition of Ctsk alleviates periodontitis and comorbid rheumatoid arthritis via downregulation of the TLR9 signalling pathway. J Clin Periodontol. 2019. PMID: 30636333. doi:10.1111/jcpe.13060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。